Invesco’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-657,083
| Closed | -$25.8M | – | 3960 |
|
|
2023
Q2 | $25.8M | Sell |
657,083
-1,371,528
| -68% | -$48.4M | 0.01% | 1225 |
|
|
2023
Q1 | $49.4M | Buy |
2,028,611
+616,275
| +44% | +$13.5M | 0.01% | 963 |
|
|
2022
Q4 | $30.2M | Buy |
1,412,336
+1,008,383
| +250% | +$21.5M | 0.01% | 1157 |
|
|
2022
Q3 | $7.25M | Buy |
403,953
+343,778
| +571% | +$4.51M | ﹤0.01% | 1996 |
|
|
2022
Q2 | $579K | Sell |
60,175
-573,332
| -91% | -$7.2M | ﹤0.01% | 3257 |
|
|
2022
Q1 | $10.7M | Buy |
633,507
+590,773
| +1,382% | +$8.73M | ﹤0.01% | 1927 |
|
|
2021
Q4 | $715K | Sell |
42,734
-2,072,768
| -98% | -$34M | ﹤0.01% | 3240 |
|
|
2021
Q3 | $34.4M | Buy |
2,115,502
+2,082,326
| +6,277% | +$22.7M | 0.01% | 1231 |
|
|
2021
Q2 | $209K | Buy |
33,176
+11,894
| +56% | +$76.7K | ﹤0.01% | 3775 |
|
|
2021
Q1 | $132K | Buy |
21,282
+2,338
| +12% | +$14.2K | ﹤0.01% | 3733 |
|
|
2020
Q4 | $131K | Sell |
18,944
-1,076,136
| -98% | -$6.89M | ﹤0.01% | 3604 |
|
|
2020
Q3 | $6.18M | Buy |
1,095,080
+843,570
| +335% | +$4.02M | ﹤0.01% | 1906 |
|
|
2020
Q2 | $1.28M | Sell |
251,510
-632,645
| -72% | -$2.64M | ﹤0.01% | 2678 |
|
|
2020
Q1 | $3.04M | Sell |
884,155
-89,169
| -9% | -$521K | ﹤0.01% | 2160 |
|
|
2019
Q4 | $8.35M | Buy |
+973,324
| New | +$3.48M | ﹤0.01% | 1873 |
|
|
2016
Q4 | – | Sell |
-118,638
| Closed | -$5.47M | – | 3716 |
|
|
2016
Q3 | $5.47M | Buy |
118,638
+38,361
| +48% | +$2.16M | ﹤0.01% | 1906 |
|
|
2016
Q2 | $4.1M | Sell |
80,277
-21,036
| -21% | -$1.05M | ﹤0.01% | 2057 |
|
|
2016
Q1 | $4.28M | Buy |
101,313
+15,121
| +18% | +$770K | ﹤0.01% | 1987 |
|
|
2015
Q4 | $6.77M | Sell |
86,192
-617
| -0.7% | -$35.7K | ﹤0.01% | 1678 |
|
|
2015
Q3 | $3.52M | Buy |
86,809
+1,850
| +2% | +$98K | ﹤0.01% | 2114 |
|
|
2015
Q2 | $4.42M | Buy |
84,959
+302
| +0.4% | +$15K | ﹤0.01% | 2078 |
|
|
2015
Q1 | $3.94M | Buy |
84,657
+2,840
| +3% | +$147K | ﹤0.01% | 2145 |
|
|
2014
Q4 | $3.67M | Buy |
+81,817
| New | +$3.44M | ﹤0.01% | 2116 |
|
Invesco's ISEE Position: Q3 2023 in Review
Invesco sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 657,083 shares — an estimated $25.8M sold.
Invesco first reported a position in ISEE in Q4 2014 and held it in 23 quarters. The position peaked at $49.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Invesco reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Invesco sold 657,083 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $25.8M.
- Invesco first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 23 quarters.
- Invesco's IVERIC bio, Inc. Common Stock position peaked at $49.4M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.